Trials / Completed
CompletedNCT02324088
Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer
Phase III Trial Assessing the Interest of a Maintenance Chemotherapy Combining Docetaxel (Taxotere) 5-FU After Induction Treatment by Aintensive Chemotherapy for Inflammatory Breast Cancers
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 174 (actual)
- Sponsor
- UNICANCER · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the benefit of adding docetaxel-5 fluorouracile (D-5FU) regimen after pre-operative epirubicin-cyclophosphamide (EC) and loco-regional treatment in inflammatory breast cancer (IBC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Docetaxel | |
| DRUG | Cyclophosphamide | |
| DRUG | Epirubicin |
Timeline
- Start date
- 2000-10-01
- Primary completion
- 2012-12-01
- Completion
- 2015-01-01
- First posted
- 2014-12-24
- Last updated
- 2021-02-21
Source: ClinicalTrials.gov record NCT02324088. Inclusion in this directory is not an endorsement.